Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation

BMC Genomics

Volumn 16, Issue 13, 2015, Pages

  Ivanov, Maxim ^a,b,c   Baranova, Ancha ^a,b,c,d,e   Butler, Timothy ^f   Spellman, Paul ^f   Mileyko, Vladislav ^a,b  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b Atlas Oncology Diagnostics   (Russian Federation)

^c MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^d RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^e GEORGE MASON UNIVERSITY   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; DNA; NUCLEOSOME;

ARTICLE; CELL FREE SYSTEM; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA FRAGMENTATION; DNA SEQUENCE; EPIGENETICS; GENE DOSAGE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; POINT MUTATION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; APOPTOSIS; BLOOD; CHEMISTRY; GENETIC EPIGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; NUCLEOSOME;

APOPTOSIS; DNA; DNA FRAGMENTATION; EPIGENESIS, GENETIC; GENE EXPRESSION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NUCLEOSOMES; SEQUENCE ANALYSIS, DNA;

EID: 84969256698     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-16-S13-S1     Document Type: Article

References (37)

1. Richmond TJ, Davey CA: The structure of DNA in the nucleosome core. Nature. 2003, 423 (6936): 145-150.
2. MacAlpine DM, Almouzni G: Chromatin and DNA replication. Cold Spring Harb Perspect Biol. 2013, 5 (8): a010207-
3. Szerlong HJ1, Hansen JC: Nucleosome distribution and linker DNA: connecting nuclear function to dynamic chromatin structure. Biochem Cell Biol. 2011, 89 (1): 24-34.
4. Goh WS, Orlov Y, Li J, Clarke ND: Blurring of high-resolution data shows that the effect of intrinsic nucleosome occupancy on transcription factor binding is mostly regional, not local. PLoS Comput Biol. 2010, 6 (1): e1000649-
5. Svaren J, Klebanow E, Sealy L, Chalkley R: Analysis of the competition between nucleosome formation and transcription factor binding. J Biol Chem. 1994, 269 (12): 9335-9344.
6. Kireeva ML, Hancock B, Cremona GH, Walter W, Studitsky VM, et al: Nature of the nucleosomal barrier to RNA polymerase II. Mol Cell. 2005, 18 (1): 97-108.
7. Iyer VR: Nucleosome positioning: bringing order to the eukaryotic genome. Trends Cell Biol. 2012, 22 (5): 250-256.
8. Henikoff S: Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet. 2008, 9: 15-26.
9. Valouev A, Ichikawa J, Tonthat T, Stuart J, Ranade S, et al: A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. Genome Res. 2008, 18 (7): 1051-1056.
10. Liu G, Feng F, Zhao X, Cai L: Nucleosome Organization around Pseudogenes in the Human Genome. Biomed Res Int. 2015, 2015: 821596-
11. Wang J, Liu S, Fu W: Nucleosome Positioning with Set of Key Positions and Nucleosome Affinity. Open Biomed Eng J. 2014, 8: 166-170.
12. Yazdi PG, Pedersen BA, Taylor JF, Khattab OS, Chen YH, et al: Nucleosome Organization in Human Embryonic Stem Cells. PLoS One. 2015, 10: e0136314-
13. Tirosh I, Barkai N: Two strategies for gene regulation by promoter nucleosomes. Genome Res. 2008, 18 (7): 1084-1091.
14. Delgado PO, Alves BC, Gehrke Fde S, Kuniyoshi RK, Wroclavski ML, et al: Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. Tumour Biol. 2013, 34 (2): 983-986.
15. Zhivotosky B, Orrenius S: Assessment of apoptosis and necrosis by DNA fragmentation and morphological criteria. Biochem Pharmacol. 2003, 66: 1527-35.
16. Hewish DR, Burgoyne LA: Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease. Biochem Biophys Res Commun. 1973, 52 (2): 504-510.
17. Matassov D, Kagan T, Leblanc J, Sikorska M, Zakeri Z: Measurement of apoptosis by DNA fragmentation. Methods Mol Biol. 2004, 282: 1-17.
18. Hughes FM, Cidlowski JA: Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases. Cell Death Differ. 1997, 4 (3): 200-208.
19. Butler TM, Johnson-Camacho K, Peto M, Wang NJ, Macey TA, et al: Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease. PLoS One. 2015, 10 (8): e0136407-
20. Valouev A, Johnson SM, Boyd SD, Smith CL, Fire AZ, et al: Determinants of nucleosome organization in primary human cells. Nature. 2011, 474 (7352): 516-520.
21. Chandrananda D, Thorne NP, Bahlo M: High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA. BMC Med Genomics. 2015, 8: 29-
22. Kotnik V, Premzl A, Skoberne M, Malovrh T, Kveder R, et al: Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis. Croat Med J. 2003, 44 (6): 707-711.
23. Zheng YWL, Chan KCA, Sun H, Jiang P, Su X, et al: Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin Chem. 2012, 58 (3): 549-558.
24. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, et al: Genome-wide in situ exon capture for selective resequencing. Nat Genet. 2007, 39 (12): 1522-1527.
25. Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, et al: Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 2011, 12 (2): R18-
26. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003, 33 Suppl: 245-254.
27. ENCODE Project Consortium: An integrated encyclopedia of DNA elements in the human genome. Nature. 2012, 489 (7414): 57-74.
28. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, et al: Dynamic regulation of nucleosome positioning in the human genome. Cell. 2008, 132 (5): 887-898.
29. Schwarzenbach H: Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Res. 2013, 15 (5): 211-
30. Heitzer E, Ulz P, Geigl JB: Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem. 2015, 61 (1): 112-123.
31. Rafii A, Vidal F, Rathat G, Alix-Panabières C: Circulating tumor cells: cornerstone of personalized medicine. J Gynecol Obstet Biol Reprod (Paris). 2014, 43 (9): 640-648.
32. Kim K, Shin DG, Park MK, Baik SH, Kim TH, et al: Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection. Ann Surg Treat Res. 2014, 86 (3): 136-142.
33. No JH, Kim K, Park KH, Kim YB: Cell-free DNA level as a prognostic biomarker for epithelial ovarian cancer. Anticancer Res. 2012, 32 (8): 3467-3471.
34. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, et al: Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 2006, 24 (26): 4270-4276.
35. Jiang P, Chan CW, Chan KC, Cheng SH, Wong J, et al: Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci USA. 2015, 112 (11): 1317-1325.
36. Young R, Pailler E, Billiot F, Drusch F, Barthelemy A, et al: Circulating tumor cells in lung cancer. Acta Cytol. 2012, 56 (2): 655-660.
37. O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, et al: Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer. 2012, 76 (1): 19-25.